Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |